News
St. Peter’s Hospital Partners with New York Oncology Hematology to Test Cancer Drug in COVID-19 Patients
Exploratory research conducted at St. Peter’s Hospital in conjunction with New York Oncology Hematology, is featured in the national medical journal, Science Immunology. The research involves the cancer drug Acalabrutinib and its potential as a possible treatment for COVID-19.